Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.
The global CRO Services for BioPharma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for CRO Services for BioPharma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRO Services for BioPharma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRO Services for BioPharma in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRO Services for BioPharma include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health, Charles River Laboratories, Medpace, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRO Services for BioPharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRO Services for BioPharma.
The CRO Services for BioPharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRO Services for BioPharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRO Services for BioPharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON
Segment by Type
Preclinical CRO
Clinical Trial CRO
Segment by Application
Commercial
Scientific Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRO Services for BioPharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global CRO Services for BioPharma 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical CRO
1.2.3 Clinical Trial CRO
1.3 麻豆原创 by Application
1.3.1 Global CRO Services for BioPharma 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRO Services for BioPharma 麻豆原创 Perspective (2019-2030)
2.2 Global CRO Services for BioPharma Growth Trends by Region
2.2.1 Global CRO Services for BioPharma 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRO Services for BioPharma Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 CRO Services for BioPharma Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 CRO Services for BioPharma 麻豆原创 Dynamics
2.3.1 CRO Services for BioPharma Industry Trends
2.3.2 CRO Services for BioPharma 麻豆原创 Drivers
2.3.3 CRO Services for BioPharma 麻豆原创 Challenges
2.3.4 CRO Services for BioPharma 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRO Services for BioPharma Players by Revenue
3.1.1 Global Top CRO Services for BioPharma Players by Revenue (2019-2024)
3.1.2 Global CRO Services for BioPharma Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global CRO Services for BioPharma 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRO Services for BioPharma Revenue
3.4 Global CRO Services for BioPharma 麻豆原创 Concentration Ratio
3.4.1 Global CRO Services for BioPharma 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRO Services for BioPharma Revenue in 2023
3.5 Global Key Players of CRO Services for BioPharma Head office and Area Served
3.6 Global Key Players of CRO Services for BioPharma, Product and Application
3.7 Global Key Players of CRO Services for BioPharma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRO Services for BioPharma Breakdown Data by Type
4.1 Global CRO Services for BioPharma Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global CRO Services for BioPharma Forecasted 麻豆原创 Size by Type (2025-2030)
5 CRO Services for BioPharma Breakdown Data by Application
5.1 Global CRO Services for BioPharma Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global CRO Services for BioPharma Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America CRO Services for BioPharma 麻豆原创 Size (2019-2030)
6.2 North America CRO Services for BioPharma 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRO Services for BioPharma 麻豆原创 Size by Country (2019-2024)
6.4 North America CRO Services for BioPharma 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRO Services for BioPharma 麻豆原创 Size (2019-2030)
7.2 Europe CRO Services for BioPharma 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRO Services for BioPharma 麻豆原创 Size by Country (2019-2024)
7.4 Europe CRO Services for BioPharma 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRO Services for BioPharma 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific CRO Services for BioPharma 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRO Services for BioPharma 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific CRO Services for BioPharma 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRO Services for BioPharma 麻豆原创 Size (2019-2030)
9.2 Latin America CRO Services for BioPharma 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRO Services for BioPharma 麻豆原创 Size by Country (2019-2024)
9.4 Latin America CRO Services for BioPharma 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRO Services for BioPharma 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa CRO Services for BioPharma 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRO Services for BioPharma 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa CRO Services for BioPharma 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PPD (Thermo Fisher)
11.1.1 PPD (Thermo Fisher) Company Details
11.1.2 PPD (Thermo Fisher) Business Overview
11.1.3 PPD (Thermo Fisher) CRO Services for BioPharma Introduction
11.1.4 PPD (Thermo Fisher) Revenue in CRO Services for BioPharma Business (2019-2024)
11.1.5 PPD (Thermo Fisher) Recent Development
11.2 Space Peptides
11.2.1 Space Peptides Company Details
11.2.2 Space Peptides Business Overview
11.2.3 Space Peptides CRO Services for BioPharma Introduction
11.2.4 Space Peptides Revenue in CRO Services for BioPharma Business (2019-2024)
11.2.5 Space Peptides Recent Development
11.3 Aurigene Pharmaceutical Services
11.3.1 Aurigene Pharmaceutical Services Company Details
11.3.2 Aurigene Pharmaceutical Services Business Overview
11.3.3 Aurigene Pharmaceutical Services CRO Services for BioPharma Introduction
11.3.4 Aurigene Pharmaceutical Services Revenue in CRO Services for BioPharma Business (2019-2024)
11.3.5 Aurigene Pharmaceutical Services Recent Development
11.4 IQVIA
11.4.1 IQVIA Company Details
11.4.2 IQVIA Business Overview
11.4.3 IQVIA CRO Services for BioPharma Introduction
11.4.4 IQVIA Revenue in CRO Services for BioPharma Business (2019-2024)
11.4.5 IQVIA Recent Development
11.5 Labcorp Drug Development
11.5.1 Labcorp Drug Development Company Details
11.5.2 Labcorp Drug Development Business Overview
11.5.3 Labcorp Drug Development CRO Services for BioPharma Introduction
11.5.4 Labcorp Drug Development Revenue in CRO Services for BioPharma Business (2019-2024)
11.5.5 Labcorp Drug Development Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel CRO Services for BioPharma Introduction
11.6.4 Parexel Revenue in CRO Services for BioPharma Business (2019-2024)
11.6.5 Parexel Recent Development
11.7 ICON plc
11.7.1 ICON plc Company Details
11.7.2 ICON plc Business Overview
11.7.3 ICON plc CRO Services for BioPharma Introduction
11.7.4 ICON plc Revenue in CRO Services for BioPharma Business (2019-2024)
11.7.5 ICON plc Recent Development
11.8 Syneos Health
11.8.1 Syneos Health Company Details
11.8.2 Syneos Health Business Overview
11.8.3 Syneos Health CRO Services for BioPharma Introduction
11.8.4 Syneos Health Revenue in CRO Services for BioPharma Business (2019-2024)
11.8.5 Syneos Health Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories CRO Services for BioPharma Introduction
11.9.4 Charles River Laboratories Revenue in CRO Services for BioPharma Business (2019-2024)
11.9.5 Charles River Laboratories Recent Development
11.10 Medpace
11.10.1 Medpace Company Details
11.10.2 Medpace Business Overview
11.10.3 Medpace CRO Services for BioPharma Introduction
11.10.4 Medpace Revenue in CRO Services for BioPharma Business (2019-2024)
11.10.5 Medpace Recent Development
11.11 SGS SA
11.11.1 SGS SA Company Details
11.11.2 SGS SA Business Overview
11.11.3 SGS SA CRO Services for BioPharma Introduction
11.11.4 SGS SA Revenue in CRO Services for BioPharma Business (2019-2024)
11.11.5 SGS SA Recent Development
11.12 KCR CRO
11.12.1 KCR CRO Company Details
11.12.2 KCR CRO Business Overview
11.12.3 KCR CRO CRO Services for BioPharma Introduction
11.12.4 KCR CRO Revenue in CRO Services for BioPharma Business (2019-2024)
11.12.5 KCR CRO Recent Development
11.13 TFS HealthScience
11.13.1 TFS HealthScience Company Details
11.13.2 TFS HealthScience Business Overview
11.13.3 TFS HealthScience CRO Services for BioPharma Introduction
11.13.4 TFS HealthScience Revenue in CRO Services for BioPharma Business (2019-2024)
11.13.5 TFS HealthScience Recent Development
11.14 Caidya
11.14.1 Caidya Company Details
11.14.2 Caidya Business Overview
11.14.3 Caidya CRO Services for BioPharma Introduction
11.14.4 Caidya Revenue in CRO Services for BioPharma Business (2019-2024)
11.14.5 Caidya Recent Development
11.15 Worldwide Clinical Trials
11.15.1 Worldwide Clinical Trials Company Details
11.15.2 Worldwide Clinical Trials Business Overview
11.15.3 Worldwide Clinical Trials CRO Services for BioPharma Introduction
11.15.4 Worldwide Clinical Trials Revenue in CRO Services for BioPharma Business (2019-2024)
11.15.5 Worldwide Clinical Trials Recent Development
11.16 CTI
11.16.1 CTI Company Details
11.16.2 CTI Business Overview
11.16.3 CTI CRO Services for BioPharma Introduction
11.16.4 CTI Revenue in CRO Services for BioPharma Business (2019-2024)
11.16.5 CTI Recent Development
11.17 Advanced Clinical
11.17.1 Advanced Clinical Company Details
11.17.2 Advanced Clinical Business Overview
11.17.3 Advanced Clinical CRO Services for BioPharma Introduction
11.17.4 Advanced Clinical Revenue in CRO Services for BioPharma Business (2019-2024)
11.17.5 Advanced Clinical Recent Development
11.18 WuXi AppTec
11.18.1 WuXi AppTec Company Details
11.18.2 WuXi AppTec Business Overview
11.18.3 WuXi AppTec CRO Services for BioPharma Introduction
11.18.4 WuXi AppTec Revenue in CRO Services for BioPharma Business (2019-2024)
11.18.5 WuXi AppTec Recent Development
11.19 Pharmaron Inc.
11.19.1 Pharmaron Inc. Company Details
11.19.2 Pharmaron Inc. Business Overview
11.19.3 Pharmaron Inc. CRO Services for BioPharma Introduction
11.19.4 Pharmaron Inc. Revenue in CRO Services for BioPharma Business (2019-2024)
11.19.5 Pharmaron Inc. Recent Development
11.20 Hangzhou Tigermed Consulting
11.20.1 Hangzhou Tigermed Consulting Company Details
11.20.2 Hangzhou Tigermed Consulting Business Overview
11.20.3 Hangzhou Tigermed Consulting CRO Services for BioPharma Introduction
11.20.4 Hangzhou Tigermed Consulting Revenue in CRO Services for BioPharma Business (2019-2024)
11.20.5 Hangzhou Tigermed Consulting Recent Development
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Company Details
11.21.2 JOINN Laboratories Business Overview
11.21.3 JOINN Laboratories CRO Services for BioPharma Introduction
11.21.4 JOINN Laboratories Revenue in CRO Services for BioPharma Business (2019-2024)
11.21.5 JOINN Laboratories Recent Development
11.22 MEDICILON
11.22.1 MEDICILON Company Details
11.22.2 MEDICILON Business Overview
11.22.3 MEDICILON CRO Services for BioPharma Introduction
11.22.4 MEDICILON Revenue in CRO Services for BioPharma Business (2019-2024)
11.22.5 MEDICILON Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON
听
听
*If Applicable.
